New scientific approaches, new clinical evaluation frameworks, new economic models… What if, to solve the antibiotic resistance crisis, we had to reinvent everything?
Michael Mourez, Director of Innovation at DEINOVE, participated in Polytechnique Insights in the file on the AMR and its issues.
Key takeaways:
- In 2015, the O’Neill report showed that antibiotic resistance could kill more people than cancer by 2050.
- The traditional approach of analysing the contents of an extract that kills the bacteria in the laboratory no longer works.
- Some laboratories are trying to use phages, specific viruses, bacteria to create new therapeutic approaches.
- As each infection is biologically unique, the meeting of a strain, host and context becomes more difficult.
Full article from Agnès Vernet, Science journalist, available here